Navigation Links
Gilead in Medical News

The Balm In Gilead Joins Saddleback Church in Thanking President Bush for His Leadership on Addressing HIV and AIDS Around the World

RICHMOND, Va., Dec. 3 /PRNewswire-USNewswire/ -- Pernessa Seele, Founder/CEO of The Balm In Gilead, joined Rick Warren, pastor of Saddleback Church, his wife, Kay and approximately 300 faith and community leaders at a Civic Forum on Global Health for a World AIDS Day ceremony recognizing President...

Monogram Biosciences Collaborates with Gilead Sciences for Elvitegravir Phase III Studies

PhenoSense GT(TM) and PhenoSense Integrase(TM) assays used to study promising new Integrase inhibitor SOUTH SAN FRANCISCO, Calif., June 18 /PRNewswire-FirstCall/ -- Monogram Biosciences, Inc., (Nasdaq: MGRM ) announced today that the Company has signed an agreement with Gi...

Religious Leaders Join The Balm In Gilead to Support The Big Coffee Project, to Help Fight HIV/AIDS in the United States and in Africa

New Initiative Launched During the 19th Annual Black Church Week of Prayer for the Healing of AIDS, March 2-8, 2008 NEW YORK, March 6 /PRNewswire/ -- The Balm In Gilead introduced today, The Big Coffee Project, a partnership between The Balm In Gilead and Sweet Unity Farms Gourme...

NCCN Updates Infection Guidelines to Include Information About H1N1 Virus (Swine Flu)

...of doripenem (Doribax(R), Ortho-McNeil-Janssen Pharmaceuticals, Inc.) to the Antibacterial Agents Tables and tenofovir disoproxil fumarate (Viread(R), gilead Sciences, Inc.) to the Antiviral Agents Tables. NCCN Clinical Practice Guidelines in Oncology(TM) are developed and updated through an evidenc...

Industry And FDA Leaders To Discuss The Evolving Science Of Cardiovascular Safety (CV) And Diabetic Drug Development

...(T2DM)," explains Program Chair Philip T. Sager, MD, FACC, Vice President, Clinical Research, Cardiopulmonary and Metabolic Clinical Development, gilead Sciences, Inc. "As a result, the Division of Metabolism and Endocrinology Products of the US Food and Drug Administration (FDA) issued a new guid...

Scleroderma Foundation Holds Gateway to Hope 2009 National Patient Education Conference in St. Louis, Mo.

...unrestricted educational grants from Actelion Pharmaceuticals US, Inc. (2009 National Silver Sponsor), Pfizer, Inc. (Silver Conference Sponsor), and gilead Sciences, Inc.(Bronze Conference Sponsor). Scholarships to attend the Conference for scleroderma patients with a demonstrated financial need were pro...

New Report Just Published: World Multiple Myeloma Therapeutics Market Report

... II-38 Merck Commences Phase II-b and Phase III Clinical Trial of Zolinza II-38 Clavis Initiates Phase II Trial of Elacytarabine II-38 gilead Sciences Commences GS 9219 Phase I Clinical Trial II-38 AstraZeneca Carries Out AZD 0530 Phase II trial II-39 European Commission Grants Appro...

HIV 'Atlas' Shows Virus Targeting Minorities

... that in every disease early detection is the key." The report, put together by the National Minority Quality Forum with support from drug company gilead Sciences, is the first ground-level look at the HIV/AIDS epidemic in the United States. "We wanted to make sure that organizations had the informat...

Video: National Minority Quality Forum Launches First U.S. HIV/AIDS Atlas

... centers, by zip code and county, among other features. The HIV/AIDS Atlas is a project of the National Minority Quality Forum, with support from gilead Sciences, Inc. About HIV/AIDS in the United States HIV/AIDS is a serious public health threat in the United States. The Centers for Dis...

MapHIV.org Shows Six Counties in Louisiana Seriously Impacted by AIDS

... centers, by zip code and county, among other features. The HIV/AIDS Atlas is a project of the National Minority Quality Forum, with support from gilead Sciences, Inc. About HIV/AIDS in the United States HIV/AIDS is a serious public health threat in the United States. The Centers for D...
Gilead in Medical Technology

Tibotec Pharmaceuticals Announces Agreement to Develop and Commercialize a New Fixed-Dose Combination of TMC278 and Truvada(R) With Gilead Sciences

CORK, Ireland, July 16 /PRNewswire/ --Tibotec Pharmaceuticals today announced that it has entered into a license and collaboration agreement with Gilead Sciences, Inc. for the development and commercialization of a new once-daily fixed-dose antiretroviral product containing Tibotec's inv...

U.S. Patent Office Rejects Key HIV/AIDS Drug Patents at PUBPAT Request: Government Finds Prior Art Submitted By PUBPAT Invalidates All of Gilead Sciences' Claims

NEW YORK, Jan. 23 /PRNewswire-USNewswire/ -- The Public Patent Foundation ("PUBPAT") announced today that the U.S. Patent & Trademark Office has rejected four key HIV/AIDS drug patents held by Gilead Sciences that relate to the drug known generically as tenofovir disoproxil fumarate (TDF), a k...

Bristol-Myers Squibb and Gilead Sciences Expand Their Alliance to Include Commercialization of ATRIPLA(R) (efavirenz 600 mg/emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg) in Europe

PRINCETON, N.J. and FOSTER CITY, Calif., Dec. 11 /PRNewswire-FirstCall/ -- Bristol-Myers Squibb Company (NYSE: BMY ) and Gilead Sciences, Inc. (Nasdaq: GILD ) today announced an agreement to commercialize ATRIPLA(R) (efavirenz 600 mg/emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg)...

Data from Preclinical Studies of Gilead Nucleotide Compound GS 9219 to be Presented at AACR

FOSTER CITY, Calif.--(BUSINESS WIRE)--Mar 15, 2007 - Gilead Sciences, Inc. (Nasdaq:GILD) today announced that the company will present data on a novel nucleotide analog, GS 9219, which has shown evidence of anti-cancer activity in preclinical studies, at the 2007 Annual Meeting of the American Asso...

Schering-Plough Expands Vicriviroc Phase II Study in Treatment-Naive Patients With HIV

...b Company prescription medicine. Please see the atazanavir product insert for information on this product. 3 Truvada is a registered trademark of gilead Sciences, Inc. Please see the Truvada product insert for information on this product. 4 Hammer SM, Schechter M, Montaner JS, et al. Treatment for...

Analysis of Long-Term Vicriviroc Data Provides Evidence of Sustained Viral Suppression, Increased CD4 Cell Counts and Tolerability in Treatment-Experienced HIV-Infected Patients

...bb Company prescription medicine. Please see the atazanavir product insert for information on this product. (7) Truvada is a registered trademark of gilead Sciences, Inc. Please see the Truvada product insert for information on this product. (8) Data collection on adverse events of anti-HIV drugs (DAD) ...

Idenix Pharmaceuticals Announces Completion of Proof-of-Concept Study for IDX899 in Treatment-Naive HIV-Infected Patients

... trademark of F. Hoffman-La Roche Ltd. Reyataz(R) is a registered trademark of Bristol-Myers Squibb Company. Truvada(R) is a registered trademark of gilead Sciences, Inc. Idenix Pharmaceuticals Contacts: Amy Sullivan 617-995-9838 (investors) Teri Dahlman 617-995-9905 (media) ...

Pharmasset Announces Initiation of Combination Study of Clevudine and Viread(R) for HBV by French National Agency for Research on AIDS and Viral Hepatitis (ANRS)

...Hepatitis (ANRS), with the support of Pharmasset, Inc. (Nasdaq: VRUS ) and gilead Sciences, Inc. (Nasdaq: GILD ), has initiated the first head-to-head study... and Exchange Commission. Viread and Hepsera are registered trademarks of gilead Sciences, Inc. ...

Schering-Plough Initiates Phase II Study With Vicriviroc in Treatment-Naive HIV-Infected Patients

...ompany prescription medicine. Please see the atazanavir product insert for information on this product. 3 Truvada is a registered trademark of gilead Sciences, Inc. Please see the Truvada product insert for information on this product. 4 Vicriviroc, a next generation CCR5 antagonist, exhibits p...

Parion Sciences Announces Phase I Clinical Results for Novel Dry Mouth Treatment

...a Phase I clinical trial in Sjogren's syndrome and a Phase II clinical trial in cystic fibrosis. In August 2007, Parion announced a collaboration with gilead Sciences focused on developing drug candidates for pulmonary diseases utilizing Parion's expertise in epithelial sodium channel blockers. Parion was f...

More>>

Gilead in Biological News

Anti-HIV drug has potential to prevent transmission in women

...uced mild or no side effects in both HIV positive and HIV negative women. Tenofovir is the active ingredient in the antiretroviral drug Viread made by gilead Sciences. Currently, there is no microbicide available that has been approved for widespread use. The tenofovir study was a safety and product acce...
Gilead in Biological Technology

ACT Announces Partnership With Gilead Sciences Inc.

SUNNYVALE, Calif., July 2 /PRNewswire/ -- Advanced Chemical Transport, one of the leading environmental companies in California, has announced a multi-year partnership with Gilead Sciences Inc., North America's third largest Bio-Med company. ACT will provide Environmental services - includi...

NovaBay(R) Pharmaceuticals Names Roy J. Wu as Senior Vice President for Business Development

...corporate financing activities. At Genelabs, Wu completed numerous licensing agreements and research collaborations with companies including Novartis, gilead and Affymetrix. Prior to Genelabs, Wu participated in the 1997 establishment of Kissei Pharma, the U.S. subsidiary of Kissei Pharmaceuticals Co...

OncoMed Pharmaceuticals Appoints Sunil Patel Senior Vice President, Corporate Development

...year. Previously, he held senior corporate development, marketing, and strategy positions with Allos Therapeutics, Connetics Corporation, Abgenix and gilead Sciences. Mr. Patel also served as a consultant with McKinsey & Company. Earlier in his career, he was a researcher at ZymoGenetics and ProCyte....

Biotech Shows Glimmer of an Upward Trend

...ect Index has fallen 7 percent - The performance of the top five biotech companies since the beginning of the year: Amgen (-13.8 percent); gilead Sciences (-16.5 percent); Celgene (-24 percent); Genzyme (-11 percent); and Biogen (+ 8.6 percent). ...

PTC Therapeutics Appoints Clare Kennedy as Vice President of Commercial Operations

...t applies in its drug discovery activities internally and in collaborations with leading biopharmaceutical companies such as Genzyme, Pfizer, Celgene, gilead and Schering-Plough. For more information, visit the company's Web site at www.ptcbio.com . ...

Biotech Drops on Weaker First Quarter Drug Sales, But Broader Markets Remain on a Roll

...viruses derived from pigs, birds, and humans. "Apart from those biotech companies that are linked to combating a potential flu pandemic, such as gilead Sciences, Novavax and BioCryst Pharmaceuticals, biotech didn't fare as well as the general markets," said G. Steven Burrill, CEO, Burrill & Compan...

Mylan's Matrix Receives First Tentative FDA Approval Under PEPFAR for Generic Truvada(R)

... the expansion of our high-quality anti-retroviral franchise." Emtricitabine and Tenofovir Disoproxil Fumarate Tablets are the generic version of gilead Sciences Inc.'s Truvada(R) Tablets. Truvada(R) is a second-line anti-HIV drug in the nucleoside reverse transcriptase inhibitor (NRTI or "nuke") fami...

Horizon Therapeutics Announces Senior Management Appointments

... management experience in international, general and operations management. Mr. Duncan was a co-founder of Corus Pharma, Inc., which was purchased by gilead Sciences, Inc. and was most recently vice president of operations at Corus where he was integral in the development and manufacturing of aztreonam lys...

Parion Sciences Receives NIH Biodefense Grant to Study Novel Methods for Mitigating Radiation-Induced Lung Injury

... is currently in Phase II clinical development for the treatment dry mouth associated with Sjogren's syndrome. The company is also collaborating with gilead Sciences on the development of drug candidates for pulmonary diseases. For more information, please visit www.parion.com . About Lovelace Re...

Parion Sciences Announces Initiation of Phase I Clinical Trial to Evaluate Safety and Tolerability of GS9411

...n Sciences, Inc. today announced that its partner, gilead Sciences (Nasdaq: GILD ), has initiated a Phase ...velopment agreement signed in August 2007 granting gilead worldwide commercialization rights to GS9411 for t...ease (COPD) and non-CF bronchiectasis. Parion and gilead jointly performed the IND-enabling studies for GS9...
Gilead in Biological Definition

Biotechnology

...-traded biotechnology companies, ranked by 2003 sales, are: Amgen Genentech Serono Biogen Idec Chiron Genzyme MedImmune gilead Sciences Cephalon Millennium Pharmaceuticals Biotechnology in fiction Star Trek The Breen use starships with organic technolo...
Other Tags
(Date:7/12/2014)... 2014 Recently, Fadhits.com, a well-known wedding dress ... long graduation dresses to its product line. In ... loyal clients. It wants to bring more benefits for its ... offered at discounted prices, up to 72% off. , As ... working hard. Its online shop is a good place for ...
(Date:7/12/2014)... New York, NY (PRWEB) July 12, 2014 ... experienced steady growth over the past five years, buoyed ... the agricultural sector's supply management system. “Eggs are a ... a result, per capita egg consumption generally grows in ... IBISWorld Industry Analyst Will McKitterick. Furthermore, demand for new ...
(Date:7/12/2014)... Fresh off their respective performances in the 2014 World Cup, ... at Sun Life Stadium in an international friendly. The World ... stars in the world of football in Colombian and Brazilian ... some of the best talent in the world in early ... team in the world according to the Fédération Internationale de ...
(Date:7/12/2014)... report, "Phthalic Anhydride and Derivatives (Plasticizers, Unsaturated Polyester Resins, ... Trends & Forecast to 2018," defines and segments phthalic ... and value. The report also estimates the demand and ... anhydride is projected to grow from an estimated $6,130.55 ... a CAGR of 5.24% from 2013 to 2018. , ...
(Date:7/12/2014)... 12, 2014 The ... Vascular Devices Market by Angioplasty Balloon ... (IVUS, OCT), IVC Filter (Retrievable), Endovascular ... analyzes and studies the major market ... U.S. and Canada. , Browse 108 ...
Breaking Medicine News(10 mins):Health News:New Collection of Long Graduation Dresses Revealed by Fadhits.com 2Health News:Chicken Egg Production in Canada Industry Market Research Report Now Available from IBISWorld 2Health News:Chicken Egg Production in Canada Industry Market Research Report Now Available from IBISWorld 3Health News:Brazil Vs. Colombia Tickets Sun Life Stadium: Ticket Down Slashes Ticket Prices for Friendly Match Between Colombia and Brazil 2Health News:Brazil Vs. Colombia Tickets Sun Life Stadium: Ticket Down Slashes Ticket Prices for Friendly Match Between Colombia and Brazil 3Health News:Phthalic Anhydride Market Projected to Reach $8.42 Billion by 2018 – Report by MarketsandMarkets 2Health News:Phthalic Anhydride Market Projected to Reach $8.42 Billion by 2018 – Report by MarketsandMarkets 3Health News:Phthalic Anhydride Market Projected to Reach $8.42 Billion by 2018 – Report by MarketsandMarkets 4Health News:North American Interventional Cardiology & Peripheral Vascular Devices Market - New Report by MarketsandMarkets 2Health News:North American Interventional Cardiology & Peripheral Vascular Devices Market - New Report by MarketsandMarkets 3Health News:North American Interventional Cardiology & Peripheral Vascular Devices Market - New Report by MarketsandMarkets 4Health News:North American Interventional Cardiology & Peripheral Vascular Devices Market - New Report by MarketsandMarkets 5
(Date:7/11/2014)... Evidence exists that cannabinoid receptor type 1 ... Ca2+ influx, and reduce neurotransmitter release. However, ... 1 can increase extracellular Ca2+ influx and ... his team, Tongji Hospital Affiliated to Tongji ... Technology, China used whole cell voltage-clamp and ...
(Date:7/11/2014)... Rio de Janeiro, Brazil- In the brains of ... mechanism that allows an electric or chemical signal ... another. Chemical synapses, which are the most abundant ... inhibitory. Synapse formation is crucial for learning, memory, ... and inhibitory synapses critical for brain function. ...
(Date:7/10/2014)... June 27, 2014  Pomerantz LLP has filed ... ("Provectus" or the "Company")(NYSE-MKT: PVCT) and certain of ... States District Court, Middle District of ... of a class consisting of all persons or ... between December 17, 2013 and May 22, 2014, ...
Breaking Biology News(10 mins):Blame it on the astrocytes 2SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action against Provectus Biopharmaceuticals, Inc. and Certain Officers - PVCT 2SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action against Provectus Biopharmaceuticals, Inc. and Certain Officers - PVCT 3
Other Contents